Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

114 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

NCT02311569

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View Trial Details
Completed

Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)

NCT01243944

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Birmingham, Alabama, United States
  • Scottsdale, Arizona, United States
  • Pomona, California, United States
  • Sacramento, California, United States
View all 102 locations
View Trial Details
Completed

Correlative Biomarker Study in Patients With Myeloproliferative Disorders

NCT00665067

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +16 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • The Palo Alto Clinic Palo Alto, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Emory Hospital Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Completed

A Study in Myeloproliferative Disorders

NCT01134120

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salt Lake City, Utah, United States
View Trial Details

Related conditions